{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T11:47:10Z","timestamp":1790423230256,"version":"4.1.0"},"reference-count":106,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2021,4,10]],"date-time":"2021-04-10T00:00:00Z","timestamp":1618012800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP19K17964"],"award-info":[{"award-number":["JP19K17964"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["JP17K09883"],"award-info":[{"award-number":["JP17K09883"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Primary aldosteronism (PA) is the most common form of secondary hypertension, with a prevalence of 5\u201310% among patients with hypertension. PA is mainly classified into two subtypes: aldosterone-producing adenoma (APA) and bilateral idiopathic hyperaldosteronism. Recent developments in genetic analysis have facilitated the discovery of mutations in KCNJ5, ATP1A1, ATP2B3, CACNA1D, CACNA1H, CLCN2, and CTNNB1 in sporadic or familial forms of PA in the last decade. These findings have greatly advanced our understanding of the mechanism of excess aldosterone synthesis, particularly in APA. Most of the causative genes encode ion channels or pumps, and their mutations lead to depolarization of the cell membrane due to impairment of ion transport. Depolarization activates voltage-gated Ca2+ channels and intracellular calcium signaling and promotes the transcription of aldosterone synthase, resulting in overproduction of aldosterone. In this article, we review recent findings on the genetic and molecular mechanisms of PA.<\/jats:p>","DOI":"10.3390\/biomedicines9040409","type":"journal-article","created":{"date-parts":[[2021,4,12]],"date-time":"2021-04-12T03:04:06Z","timestamp":1618196646000},"page":"409","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":24,"title":["Update on Genetics of Primary Aldosteronism"],"prefix":"10.3390","volume":"9","author":[{"given":"Kiyotaka","family":"Itcho","sequence":"first","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9225-8193","authenticated-orcid":false,"given":"Kenji","family":"Oki","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5400-1162","authenticated-orcid":false,"given":"Haruya","family":"Ohno","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayasu","family":"Yoneda","sequence":"additional","affiliation":[{"name":"Department of Molecular and Internal Medicine, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima 734-8551, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,4,10]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: Case detection, diagnosis, and treatment: An endocrine society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-Term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: A retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1161\/HYPERTENSIONAHA.118.11568","article-title":"Renal outcomes in medically and surgically treated primary aldosteronism","volume":"72","author":"Hundemer","year":"2018","journal-title":"Hypertension"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1161\/HYPERTENSIONAHA.117.10596","article-title":"Adrenalectomy Lowers Incident Atrial Fibrillation in Primary Aldosteronism Patients at Long Term","volume":"71","author":"Rossi","year":"2018","journal-title":"Hypertension"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1038\/ng.2550","article-title":"Somatic mutations in ATP1A1 and ATP2B3 lead to aldosterone-producing adenomas and secondary hypertension","volume":"45","author":"Beuschlein","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/ng.2695","article-title":"Somatic and germline CACNA1D calcium channel mutations in aldosterone-producing adenomas and primary aldosteronism","volume":"45","author":"Scholl","year":"2013","journal-title":"Nat. Genet."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"e06315","DOI":"10.7554\/eLife.06315","article-title":"Recurrent gain of function mutation in calcium channel CACNA1H causes early-onset hypertension with primary aldosteronism","volume":"4","author":"Scholl","year":"2015","journal-title":"eLife"},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1038\/s41588-018-0048-5","article-title":"CLCN2 chloride channel mutations in familial hyperaldosteronism type II","volume":"50","author":"Scholl","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41588-018-0053-8","article-title":"A gain-of-function mutation in the CLCN2 chloride channel gene causes primary aldosteronism","volume":"50","author":"Daniil","year":"2018","journal-title":"Nat. Genet."},{"key":"ref_13","first-page":"1","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"Maharjan","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.111.188532","article-title":"Visinin-like 1 is upregulated in aldosterone-producing adenomas with KCNJ5 mutations and protects from calcium-induced apoptosis","volume":"59","author":"Williams","year":"2012","journal-title":"Hypertension"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1161\/HYPERTENSIONAHA.117.10205","article-title":"Calneuron 1 Increased Ca 2+ in the Endoplasmic Reticulum and Aldosterone Production in Aldosterone-Producing Adenoma","volume":"71","author":"Kobuke","year":"2018","journal-title":"Hypertension"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/jc.2017-00950","article-title":"GSTA1 expression is correlated with aldosterone level in KCNJ5-mutated adrenal aldosterone-producing adenoma","volume":"103","author":"Li","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1161\/HYPERTENSIONAHA.117.09156","article-title":"Physiological and Pathological Roles in Human Adrenal of the Glomeruli-Defining Matrix Protein NPNT (Nephronectin)","volume":"69","author":"Garg","year":"2017","journal-title":"Hypertension"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1161\/HYPERTENSIONAHA.119.14062","article-title":"Endoplasmic Reticulum Chaperone Calmegin Is Upregulated in Aldosterone-Producing Adenoma and Associates with Aldosterone Production","volume":"75","author":"Itcho","year":"2020","journal-title":"Hypertension"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1210\/jc.2013-3495","article-title":"Integrated analysis of genome-wide methylation and gene expression shows epigenetic regulation of CYP11B2 in aldosteronomas","volume":"99","author":"Howard","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1530\/EJE-15-0148","article-title":"Integration of transcriptome and methylome analysis of aldosterone-producing adenomas","volume":"173","author":"Murakami","year":"2015","journal-title":"Eur. J. Endocrinol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1161\/HYPERTENSIONAHA.116.08313","article-title":"Hypomethylation of CYP11B2 in Aldosterone-Producing Adenoma","volume":"68","author":"Yoshii","year":"2016","journal-title":"Hypertension"},{"key":"ref_22","first-page":"1","article-title":"DNA Methylation of Steroidogenic Enzymes in Benign Adrenocortical Tumors: New Insights in Aldosterone-Producing Adenomas","volume":"105","author":"Morandi","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_23","first-page":"1109","article-title":"Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone","volume":"95","author":"Sutherland","year":"1966","journal-title":"Can. Med. Assoc. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/355262a0","article-title":"A chimaeric ll\u03b2-hydroxylase\/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension","volume":"355","author":"Lifton","year":"1992","journal-title":"Nature"},{"key":"ref_25","first-page":"4310","article-title":"Aldosterone-producing adenomas do not contain glucocorticoid-remediable aldosteronism chimeric gene duplications","volume":"81","author":"Carroll","year":"1996","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1210\/en.2011-1733","article-title":"Potassium channel mutant KCNJ5 T158A expression in HAC-15 cells increases aldosterone synthesis","volume":"153","author":"Oki","year":"2012","journal-title":"Endocrinology"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/JME-15-0324","article-title":"Mutated KCNJ5 activates the acute and chronic regulatory steps in aldosterone production","volume":"57","author":"Hattangady","year":"2016","journal-title":"J. Mol. Endocrinol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1210\/en.2013-1944","article-title":"Pharmacology and pathophysiology of mutated KCNJ5 found in adrenal aldosterone-producing adenomas","volume":"155","author":"Tauber","year":"2014","journal-title":"Endocrinology"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"E1765","DOI":"10.1210\/jc.2014-1927","article-title":"A novel KCNJ5-insT149 somatic mutation close to, but outside, the selectivity filter causes resistant hypertension by loss of selectivity for potassium","volume":"99","author":"Kuppusamy","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1210\/jc.2011-3132","article-title":"Effect of KCNJ5 mutations on gene expression in aldosterone-producing adenomas and adrenocortical cells","volume":"97","author":"Monticone","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1507\/endocrj.EJ20-0478","article-title":"The landscape of molecular mechanism for aldosterone production in aldosterone-producing adenoma","volume":"67","author":"Oki","year":"2020","journal-title":"Endocr. J."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.mce.2013.01.018","article-title":"KCNJ5 mutations in aldosterone producing adenoma and relationship with adrenal cortex remodeling","volume":"371","author":"Boulkroun","year":"2013","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1161\/HYPERTENSIONAHA.119.13476","article-title":"Primary Aldosteronism: KCNJ5 Mutations and Adrenocortical Cell Growth","volume":"74","author":"Yang","year":"2019","journal-title":"Hypertension"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"E155","DOI":"10.1210\/jc.2014-3009","article-title":"Novel KCNJ5 mutations in sporadic aldosterone-producing adenoma reduce Kir3.4 membrane abundance","volume":"100","author":"Cheng","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1161\/HYPERTENSIONAHA.113.01733","article-title":"Somatic ATP1A1, ATP2B3, and KCNJ5 mutations in aldosterone-producing adenomas","volume":"63","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1210\/me.2015-1195","article-title":"Novel insertion mutation in KCNJ5 channel produces constitutive aldosterone release from H295R cells","volume":"29","author":"Hardege","year":"2015","journal-title":"Mol. Endocrinol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2018-01004","article-title":"Targeted molecular characterization of aldosterone-producing adenomas in white americans","volume":"103","author":"Nanba","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/cen.12873","article-title":"Novel somatic mutations in primary hyperaldosteronism are related to the clinical, radiological and pathological phenotype","volume":"83","author":"Scholl","year":"2015","journal-title":"Clin. Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"\u00c5kerstr\u00f6m, T., Crona, J., Delgado Verdugo, A., Starker, L.F., Cupisti, K., Willenberg, H.S., Knoefel, W.T., Saeger, W., Feller, A., and Ip, J. (2012). Comprehensive re-sequencing of adrenal aldosterone producing lesions reveal three somatic mutations near the KCNJ5 potassium channel selectivity filter. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0041926"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"K1","DOI":"10.1530\/EJE-16-0262","article-title":"Double adrenocortical adenomas harboring independent KCNJ5 and PRKACA somatic mutations","volume":"175","author":"Nanba","year":"2016","journal-title":"Eur. J. Endocrinol."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1161\/HYPERTENSIONAHA.114.03346","article-title":"Clinical Characteristics of Somatic Mutations in Chinese Patients With Aldosterone-Producing Adenoma","volume":"65","author":"Ke","year":"2015","journal-title":"Hypertension"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.118.12070","article-title":"Genetic characteristics of aldosterone-producing adenomas in blacks","volume":"73","author":"Nanba","year":"2019","journal-title":"Hypertension"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1097\/HJH.0000000000001578","article-title":"KCNJ5 mutation as a predictor for resolution of hypertension after surgical treatment of aldosterone-producing adenoma","volume":"36","author":"Kitamoto","year":"2018","journal-title":"J. Hypertens."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/HYPERTENSIONAHA.111.186239","article-title":"Somatic mutations affecting the selectivity filter of KCNJ5 are frequent in 2 large unselected collections of adrenal aldosteronomas","volume":"59","author":"Azizan","year":"2012","journal-title":"Hypertension"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Williams","year":"2014","journal-title":"Hypertension"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1210\/jc.2011-2885","article-title":"Expression and mutations of KCNJ5 mRNA in Japanese patients with aldosterone-producing adenomas","volume":"97","author":"Taguchi","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_47","doi-asserted-by":"crossref","unstructured":"Ram Hong, A., Kim, J.H., Song, Y.S., Lee, K.E., Seo, S.H., Seong, M.W., Shin, C.S., Kim, S.W., and Kim, S.Y. (2016). Genetics of aldosterone-producing adenoma in Korean patients. PLoS ONE, 11.","DOI":"10.1371\/journal.pone.0147590"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1507\/endocrj.EJ16-0243","article-title":"Characteristics of japanese aldosterone-producing adenomas with KCNJ5 mutations","volume":"64","author":"Okamura","year":"2017","journal-title":"Endocr. J."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1210\/js.2018-00097","article-title":"Prevalence of somatic KCNJ5 mutations in Thai patients with aldosterone-producing adrenal adenomas","volume":"2","author":"Warachit","year":"2018","journal-title":"J. Endocr. Soc."},{"key":"ref_50","first-page":"1","article-title":"Prevalence and clinical correlates of somatic mutation in aldosterone producing adenoma-Taiwanese population","volume":"5","author":"Wu","year":"2015","journal-title":"Sci. Rep."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"E1089","DOI":"10.1210\/jc.2015-2149","article-title":"A meta-analysis of somatic KCNJ5 K+ channel mutations in 1636 patients with an aldosterone-producing adenoma","volume":"100","author":"Lenzini","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1507\/endocrj.EJ12-0247","article-title":"KCNJ5 mutations in aldosterone- and cortisol-co-secreting adrenal adenomas","volume":"59","author":"Yamada","year":"2012","journal-title":"Endocr. J."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/HYPERTENSIONAHA.120.15328","article-title":"Presence of subclinical hypercortisolism in clinical aldosterone-producing adenomas predicts lower clinical success","volume":"76","author":"Peng","year":"2020","journal-title":"Hypertension"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1097\/HJH.0000000000000186","article-title":"KCNJ5 gene somatic mutations affect cardiac remodelling but do not preclude cure of high blood pressure and regression of left ventricular hypertrophy in primary aldosteronism","volume":"32","author":"Rossi","year":"2014","journal-title":"J. Hypertens."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"191","DOI":"10.5551\/jat.24455","article-title":"Comparison of cardiovascular complications in patients with and without KCNJ5 gene mutations harboring aldosterone-producing adenomas","volume":"22","author":"Kitamoto","year":"2015","journal-title":"J. Atheroscler. Thromb."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1161\/HYPERTENSIONAHA.120.15679","article-title":"KCNJ5 Somatic Mutations in Aldosterone-Producing Adenoma Are Associated With a Worse Baseline Status and Better Recovery of Left Ventricular Remodeling and Diastolic Function","volume":"77","author":"Chang","year":"2021","journal-title":"Hypertension"},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"4695","DOI":"10.1210\/jc.2019-00531","article-title":"KCNJ5 Somatic Mutation Is a Predictor of Hypertension Remission after Adrenalectomy for Unilateral Primary Aldosteronism","volume":"104","author":"Vilela","year":"2019","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1210\/jc.2015-3239","article-title":"Molecular heterogeneity in aldosterone-producing adenomas","volume":"101","author":"Nanba","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1210\/jc.2018-00738","article-title":"Aldosterone Suppression by Dexamethasone in Patients with KCNJ5-Mutated Aldosterone-Producing Adenoma","volume":"103","author":"Inoue","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1210\/clinem\/dgz235","article-title":"Histological Characterization of Aldosterone-producing Adrenocortical Adenomas with Different Somatic Mutations","volume":"105","author":"Ono","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1161\/HYPERTENSIONAHA.115.06186","article-title":"Genotype-Specific Steroid Profiles Associated With Aldosterone-Producing Adenomas","volume":"67","author":"Williams","year":"2016","journal-title":"Hypertension"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1161\/HYPERTENSIONAHA.118.12064","article-title":"18-Oxocortisol Synthesis in Aldosterone-Producing Adrenocortical Adenoma and Significance of KCNJ5 Mutation Status","volume":"73","author":"Tezuka","year":"2019","journal-title":"Hypertension"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1161\/HYPERTENSIONAHA.114.04453","article-title":"Measurement of peripheral plasma 18-oxocortisol can discriminate unilateral adenoma from bilateral diseases in patients with primary aldosteronism","volume":"65","author":"Satoh","year":"2015","journal-title":"Hypertension"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1373\/clinchem.2015.251199","article-title":"Mass spectrometry-based adrenal and peripheral venous steroid profiling for subtyping primary aldosteronism","volume":"62","author":"Eisenhofer","year":"2016","journal-title":"Clin. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1161\/HYPERTENSIONAHA.119.13866","article-title":"Comprehensive Analysis of Steroid Biomarkers for Guiding Primary Aldosteronism Subtyping","volume":"75","author":"Turcu","year":"2020","journal-title":"Hypertension"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e2016209","DOI":"10.1001\/jamanetworkopen.2020.16209","article-title":"Use of Steroid Profiling Combined With Machine Learning for Identification and Subtype Classification in Primary Aldosteronism","volume":"3","author":"Eisenhofer","year":"2020","journal-title":"JAMA Netw. Open"},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"3117","DOI":"10.1210\/jc.2008-0594","article-title":"A novel form of human mendelian hypertension featuring nonglucocorticoid- remediable aldosteronism","volume":"93","author":"Geller","year":"2008","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1210\/jc.2012-1334","article-title":"A novel point mutation in the KCNJ5 gene causing primary hyperaldosteronism and early-onset autosomal dominant hypertension","volume":"97","author":"Charmandari","year":"2012","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"E114","DOI":"10.1210\/jc.2014-3636","article-title":"A case of severe hyperaldosteronism caused by a de novo mutation affecting a critical salt bridge Kir3.4 residue","volume":"100","author":"Monticone","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"2533","DOI":"10.1073\/pnas.1121407109","article-title":"Hypertension with or without adrenal hyperplasia due to different inherited mutations in the potassium channel KCNJ5","volume":"109","author":"Scholl","year":"2012","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1161\/HYPERTENSIONAHA.111.183996","article-title":"KCNJ5 mutations in European families with nonglucocorticoid remediable familial hyperaldosteronism","volume":"59","author":"Mulatero","year":"2012","journal-title":"Hypertension"},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1210\/jc.2013-2428","article-title":"A novel Y152C KCNJ5 mutation responsible for familial hyperaldosteronism type III","volume":"98","author":"Monticone","year":"2013","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1159\/000358197","article-title":"Discordant genotype-phenotype correlation in familial hyperaldosteronism type III with KCNJ5 gene mutation: A patient report and review of the literature","volume":"82","author":"Adachi","year":"2014","journal-title":"Horm. Res. Paediatr."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.mce.2016.07.031","article-title":"Somatic KCNJ5 mutation occurring early in adrenal development may cause a novel form of juvenile primary aldosteronism","volume":"441","author":"Tamura","year":"2017","journal-title":"Mol. Cell. Endocrinol."},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/ajh\/hpz172","article-title":"Mosaicism for KCNJ5 Causing Early-Onset Primary Aldosteronism due to Bilateral Adrenocortical Hyperplasia","volume":"33","author":"Maria","year":"2020","journal-title":"Am. J. Hypertens."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"4582","DOI":"10.1210\/en.2015-1466","article-title":"Pathogenesis of adrenal aldosterone-producing adenomas carrying mutations of the Na+\/K+-ATPase","volume":"156","author":"Stindl","year":"2015","journal-title":"Endocrinology"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1210\/clinem\/dgaa595","article-title":"Prevalence of Somatic Mutations in Aldosterone-Producing Adenomas in Japanese Patients","volume":"105","author":"Nanba","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1161\/HYPERTENSIONAHA.119.14177","article-title":"Genetic, cellular, and molecular heterogeneity in adrenals with aldosterone-producing adenoma","volume":"75","author":"Boulkroun","year":"2020","journal-title":"Hypertension"},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1210\/jc.2015-3284","article-title":"Clinical and steroidogenic characteristics of aldosterone-producing adenomas with ATPase or CACNA1D gene mutations","volume":"101","author":"Kitamoto","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-41525-2","article-title":"RNA Sequencing Provides Novel Insights into the Transcriptome of Aldosterone Producing Adenomas","volume":"9","author":"Backman","year":"2019","journal-title":"Sci. Rep."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1210\/en.2015-2029","article-title":"Cellular pathophysiology of an adrenal adenoma-associated mutant of the plasma membrane Ca2+-ATPase ATP2B3","volume":"157","author":"Tauber","year":"2016","journal-title":"Endocrinology"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: One node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s00424-020-02418-w","article-title":"De novo CACAN1D Ca2+ channelopathies: Clinical phenotypes and molecular mechanism","volume":"472","author":"Ortner","year":"2020","journal-title":"Pflug. Arch. Eur. J. Physiol."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"49","DOI":"10.17116\/jnevro201811812149","article-title":"The third case report a patient with primary aldosteronism, seizures, and neurologic abnormalities (PASNA) syndrome de novo variant mutations in the CACNA1D gene","volume":"118","author":"Semenova","year":"2018","journal-title":"Zhurnal Nevrol. Psikhiatrii Im. S.S. Korsakova"},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1080\/19336950.2020.1761171","article-title":"A de novo CACNA1D missense mutation in a patient with congenital hyperinsulinism, primary hyperaldosteronism and hypotonia","volume":"14","year":"2020","journal-title":"Channels"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"2593","DOI":"10.1242\/dev.021493","article-title":"Targeted disruption \u03b2-catenin in Sf1-expressing cells impairs development and maintenance of the adrenal cortex","volume":"135","author":"Kim","year":"2008","journal-title":"Development"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"4753","DOI":"10.1210\/en.2011-1205","article-title":"Aldosterone-producing adenoma formation in the adrenal cortex involves expression of stem\/progenitor cell markers","volume":"152","author":"Boulkroun","year":"2011","journal-title":"Endocrinology"},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosteroneproducing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum. Mol. Genet."},{"key":"ref_90","first-page":"1","article-title":"The prevalence of CTNNB1 mutations in primary aldosteronism and consequences for clinical outcomes","volume":"7","author":"Wu","year":"2017","journal-title":"Sci. Rep."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"7622","DOI":"10.1158\/0008-5472.CAN-05-0593","article-title":"Mutations of \u03b2-catenin in adrenocortical tumors: Activation of the Wnt signaling pathway is a frequent event in both benign and malignant adrenocortical tumors","volume":"65","author":"Tissier","year":"2005","journal-title":"Cancer Res."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1093\/hmg\/ddq029","article-title":"Constitutive \u03b2-catenin activation induces adrenal hyperplasia and promotes adrenal cancer development","volume":"19","author":"Berthon","year":"2010","journal-title":"Hum. Mol. Genet."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1111\/j.1440-1681.1991.tb01446.x","article-title":"Clinical and pathological diversity of primary aldosteronism, including a new familial variety","volume":"18","author":"Gordon","year":"1991","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1440-1681.1992.tb00462.x","article-title":"Familial hyperaldosteronism type II: Five families with a new variety of primary aldosteronism","volume":"19","author":"Stowasser","year":"1992","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"K37","DOI":"10.1530\/EJE-19-0377","article-title":"A somatic mutation in CLCN2 identified in a sporadic aldosterone-producing adenoma","volume":"181","author":"Dutta","year":"2019","journal-title":"Eur. J. Endocrinol."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"bvaa123","DOI":"10.1210\/jendso\/bvaa123","article-title":"Identification of Somatic Mutations in CLCN2 in Aldosterone-Producing Adenomas","volume":"4","author":"Rege","year":"2020","journal-title":"J. Endocr. Soc."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.ebiom.2016.10.002","article-title":"CACNA1H Mutations Are Associated With Different Forms of Primary Aldosteronism","volume":"13","author":"Daniil","year":"2016","journal-title":"EBioMedicine"},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1161\/HYPERTENSIONAHA.119.14349","article-title":"Somatic CACNA1H Mutation As a Cause of Aldosterone-Producing Adenoma","volume":"75","author":"Nanba","year":"2020","journal-title":"Hypertension"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1056\/NEJMoa1310359","article-title":"Constitutive Activation of PKA Catalytic Subunit in Adrenal Cushing\u2019s Syndrome","volume":"370","author":"Beuschlein","year":"2014","journal-title":"N. Engl. J. Med."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3010","DOI":"10.1210\/jc.2016-1700","article-title":"PRKACA somatic mutations are rare findings in aldosterone-producing adenomas","volume":"101","author":"Rhayem","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1507\/endocrj.EJ15-0642","article-title":"Gnas mutations in adrenal aldosterone-producing adenomas","volume":"63","author":"Nakajima","year":"2016","journal-title":"Endocr. J."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"E900","DOI":"10.1210\/jc.2014-4167","article-title":"Primary aldosteronism and ARMC5 variants","volume":"100","author":"Zilbermint","year":"2015","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/jhh.2015.98","article-title":"ARMC5 mutation analysis in patients with primary aldosteronism and bilateral adrenal lesions","volume":"30","author":"Mulatero","year":"2016","journal-title":"J. Hum. Hypertens."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1210\/clinem\/dgaa290","article-title":"The Association of ARMC5 with the Renin-Angiotensin-Aldosterone System, Blood Pressure, and Glycemia in African Americans","volume":"105","author":"Joseph","year":"2020","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s12672-019-00375-0","article-title":"Molecular and Electrophysiological Analyses of ATP2B4 Gene Variants in Bilateral Adrenal Hyperaldosteronism","volume":"11","author":"Hattangady","year":"2020","journal-title":"Horm. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/ERC-20-0384","article-title":"Phosphodiesterase 2A and 3B variants are associated with primary aldosteronism","volume":"28","author":"Maria","year":"2021","journal-title":"Endocr. Relat. Cancer"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/4\/409\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T14:27:46Z","timestamp":1760365666000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/4\/409"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4,10]]},"references-count":106,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2021,4]]}},"alternative-id":["biomedicines9040409"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9040409","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,4,10]]}}}